José E. Almeida is the Chair of the Board, President, and Chief Executive Officer at Baxter International Inc., a leading global medical technology company. Born in Brazil, Almeida's career in the medical industry spans over three decades, showcasing his deep expertise and leadership in the field. Before joining Baxter in 2016, he served as the Chairman, President, and CEO of Covidien plc, where he significantly expanded the company's global presence and product portfolio. His strategic vision and operational excellence were instrumental in driving Covidien's growth until its acquisition by Medtronic in 2015. At Baxter International Inc., Almeida has been pivotal in steering the company through a transformative period, focusing on innovation and expanding its reach in medical technology solutions. Under his leadership, Baxter has enhanced its product offerings in critical areas such as renal care, hospital products, and pharmaceuticals, aiming to improve patient outcomes worldwide. Almeida's commitment to advancing healthcare is evident in his initiatives to foster a culture of continuous improvement and technological advancement within Baxter. His strategic foresight has positioned Baxter as a leader in the medical technology sector, dedicated to meeting the evolving needs of healthcare providers and patients. In addition to his corporate achievements, José E. Almeida is recognized for his contributions to the broader healthcare community. He serves on several influential boards and committees, advocating for advancements in medical technology and patient care. Almeida's leadership extends beyond the boardroom, as he actively participates in initiatives aimed at improving global health standards and accessibility to medical solutions. His dedication to excellence and innovation continues to drive Baxter's mission to save and sustain lives, solidifying his reputation as a visionary leader in the medical technology industry.